CPC Subgroup
C12Y 302/01 Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Full Title
Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2) > Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
Filing statistics
CPC C12Y 302/01 belongs to the parent subclass C12Y, which recorded 144,590 patent applications worldwide between 2013 and 2023. Annual filings grew from 9,773 in 2013 to 11,938 in 2023 (+22%), peaking at 15,970 applications in 2021. The most active applicants in class C12 are HARVARD UNIVERSITY (8,321 applications), CHINESE ACADEMY OF SCIENCES (7,486 applications) and UNIVERSITY OF CALIFORNIA (7,320 applications).
Source: EPO PATSTAT, worldwide filings
168 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- C12Y 302/01001 Alpha-amylase (3.2.1.1)
- C12Y 302/01002 Beta-amylase (3.2.1.2)
- C12Y 302/01003 Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase
- C12Y 302/01004 Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase
- C12Y 302/01006 Endo-1,3(4)-beta-glucanase (3.2.1.6)
- C12Y 302/01007 Inulinase (3.2.1.7)
- C12Y 302/01008 Endo-1,4-beta-xylanase (3.2.1.8)
- C12Y 302/0101 Oligo-1,6-glucosidase (3.2.1.10), i.e. sucrase
- C12Y 302/01011 Dextranase (3.2.1.11)
- C12Y 302/01014 Chitinase (3.2.1.14)
- C12Y 302/01015 Polygalacturonase (3.2.1.15)
- C12Y 302/01017 Lysozyme (3.2.1.17)
- C12Y 302/01018 Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
- C12Y 302/01019 Heparinase (3.2.1.19)
- C12Y 302/0102 Alpha-glucosidase (3.2.1.20)
- C12Y 302/01021 Beta-glucosidase (3.2.1.21)
- C12Y 302/01022 Alpha-galactosidase (3.2.1.22)
- C12Y 302/01023 Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
- C12Y 302/01024 Alpha-mannosidase (3.2.1.24)
- C12Y 302/01025 Beta-mannosidase (3.2.1.25), i.e. mannanase
Top Applicants
Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT
- HARVARD UNIVERSITY US 8,321
- CHINESE ACADEMY OF SCIENCES 7,486
- UNIVERSITY OF CALIFORNIA US 7,320
- REGENERON PHARMACEUTICALS US 5,003
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 4,292
- UNIVERSITY OF PENNSYLVANIA US 4,213
- CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 4,113
- JIANGNAN UNIVERSITY 3,961
- ROCHE CH 3,792
- ILLUMINA US 3,692